• Managing Risk
  • Audience (Potential Investors, Partners, Recruits)
  • Risk/Return
• Problem & Solution Statement
• Market Risk
  • Market Opportunity
  • Market Size
• Technology/Product Risk
  • Description
  • Feasibility
• Execution/Team Risk
  • Team Strengths
  • Key Hires
  • Market Entry Strategy
  • Manufacturing/Operations
• Financial Risk
  • Financial Plan
  • Exit Strategies
• Mistakes to Avoid

Gerard Eldering is Founder and President of InnovateTech Ventures, specializing in venture creation based on inventions licensed from universities and research institutions. Since the company’s founding in 2007, InnovateTech has supported numerous mid-Atlantic universities and co-founded three start-up companies including AlphaDetect and Trilumen. Gerard has been working in the technology transfer community for more than a decade and is passionate about the creation of professionally managed and funded start-up companies. Prior to launching InnovateTech, he founded and served as Director of the Technology Transfer Office at The MITRE Corporation. He is an MBA and a registered patent agent.

Jim Chung is Director of the Office of Entrepreneurship at George Washington University, where he is responsible for entrepreneurship programs and technology transfer. Previously, he was Director of the Mtech VentureAccelerator at the University of Maryland, where he assisted faculty and students in launching start-up companies based on University of Maryland technology. Before the University of Maryland, Chung was Director of New Business Development at the Corporate Executive Board, where he helped establish the company's mergers and acquisitions capabilities, including the acquisition of IT Toolbox. Prior to the Corporate Executive Board, Chung was vice president of Cherington Capital (now Intervale Capital), a private equity firm investing in middle-market manufacturing and service businesses in the oil and gas industry, where he helped execute the acquisition of Ulterra Drilling Technologies (formerly Rockbit International). Chung spent five years prior to joining Cherington Capital in the venture capital industry, most recently at incTANK Ventures, an early stage venture capital firm, where he served as managing director. He has experience leading or co-leading investments into medical device, software, and information technology companies, including investments in AgaMatrix Inc. and Nexaweb Technologies Inc. Before entering the private sector, Chung was an academic researcher studying how business, government and academia work together to create new innovation in high technology industries. He served as a research fellow at several institutions during his 10-year academic career, including Harvard University, MIT and the University of Tokyo.